The faces and friends of RhoGDI2

被引:0
|
作者
Erin M. Griner
Dan Theodorescu
机构
[1] University of Virginia,Center for Cell Signaling and Department of Microbiology, Immunology and Cancer Biology
[2] University of Colorado,Department of Pharmacology
[3] University of Colorado Comprehensive Cancer Center,Department of Surgery
[4] University of Colorado Comprehensive Cancer Center,undefined
来源
关键词
RhoGDI2; GTPase; Metastasis; Bladder neoplasms;
D O I
暂无
中图分类号
学科分类号
摘要
RhoGDI2 is a guanine nucleotide dissociation inhibitor (GDI) specific for the Rho family of small GTPases that plays dual opposite roles in tumor progression, being both a promoter in tissues such as breast and a metastasis suppressor in tissues such as the bladder. Despite a clear role for this protein in modulating the invasive and metastatic process, the mechanisms through which RhoGDI2 executes these functions remain unclear. This review will highlight the current state of our knowledge regarding how RhoGDI2 functions in metastasis with a focus on bladder cancer and will also seek to highlight other potential underappreciated avenues through which this protein may affect cancer cell behavior.
引用
收藏
页码:519 / 528
页数:9
相关论文
共 50 条
  • [41] RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer
    Koh, Sung Ae
    Kim, Min Kyoung
    Lee, Kyung Hee
    Kim, Sang Woon
    Kim, Jae-Ryong
    CLINICAL & EXPERIMENTAL METASTASIS, 2014, 31 (07) : 805 - 815
  • [42] The metastasis suppressor RhoGDI2 suppresses expression of Versican, an invasion associated and macrophage stimulatory molecule
    Said, Neveen
    Theodorescu, Dan
    CANCER RESEARCH, 2009, 69
  • [43] Association of RhoGDI2 with HGF-mediated tumor invasion through VEGF in stomach cancer
    Koh, Sung Ae
    Lee, Kyung Hee
    Choi, Eun Young
    Kim, Min Kyoung
    Kim, Jae-Ryong
    Kim, Sang Woon
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] RhoGDI2 induced malignant phenotypes of pancreatic cancer cells via regulating Snail expression
    Bin Yi
    You Hu
    Dongming Zhu
    Jun Yao
    Jian Zhou
    Yi Zhang
    Zhilong He
    Lifeng Zhang
    Zixiang Zhang
    Jian Yang
    Yuchen Tang
    Yujie Huang
    Dechun Li
    Qiuhua Liu
    Genes & Genomics, 2022, 44 : 561 - 569
  • [45] RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells
    Cho, Hee Jun
    Park, Sun-Mi
    Kim, In-Kyu
    Nam, In-Koo
    Baek, Kyoung Eun
    Im, Min-Ju
    Yoo, Jong-Min
    Park, Seung-Ho
    Ryu, Ki-Jun
    Han, Hyun-Tak
    Kim, Hyo-Jin
    Hong, Soon-Chan
    Kim, Kwang Dong
    Pak, Yunbae
    Kim, Jae Won
    Lee, Chang Won
    Yoo, Jiyun
    ONCOTARGET, 2014, 5 (06) : 1554 - 1564
  • [46] Serum Response Factor regulates expression of the Rhogdi2 metastasis suppressor gene in bladder cancer cells
    Harding, Michael A.
    Titus, Brian J.
    Smith, Steven C.
    Theodorescu, Dan
    CANCER RESEARCH, 2006, 66 (08)
  • [47] Biphasic expression of RhoGDI2 in the progression of breast cancer and its negative relation with lymph node metastasis
    Hu, Li De
    Zou, Hua Fei
    Zhan, Shu Xuan
    Cao, Kai Ming
    ONCOLOGY REPORTS, 2007, 17 (06) : 1383 - 1389
  • [48] Increased RhoGDI2 and peroxiredoxin 5 levels in asthmatic murine model of β2-adrenoceptor desensitization:: A proteomics approach
    Liu Hua
    Zhou Lin-fu
    Zhang Qian
    Qian Fen-hong
    Yin Kai-sheng
    Huang Mao
    Zhang Xi-long
    CHINESE MEDICAL JOURNAL, 2008, 121 (04) : 355 - 362
  • [49] RhoGDI2蛋白在膀胱癌组织中的表达及意义
    李秀宁
    王琪
    高超
    刘翰楠
    唐勇
    广西医科大学学报, 2015, 32 (02) : 173 - 176
  • [50] Rho GDP dissociation inhibitor 2 (RhoGDI2) is a functionally important molecule in EGFR signaling pathway in pulmonary adenocarcinoma
    Kang, Jin-Hyoung
    Shin, Jung-Young
    Zhang, XiangHua
    Yoon, Seong-Ae
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : S237 - S238